103 related articles for article (PubMed ID: 10519248)
21. Localization of parasite antigens in Cryptosporidium parvum-infected epithelial cells using monoclonal antibodies.
McDonald V; McCrossan MV; Petry F
Parasitology; 1995 Apr; 110 ( Pt 3)():259-68. PubMed ID: 7536912
[TBL] [Abstract][Full Text] [Related]
22. An immunoglobulin G1 monoclonal antibody highly specific to the wall of Cryptosporidium oocysts.
Weir C; Vesey G; Slade M; Ferrari B; Veal DA; Williams K
Clin Diagn Lab Immunol; 2000 Sep; 7(5):745-50. PubMed ID: 10973448
[TBL] [Abstract][Full Text] [Related]
23. Multiple oral inoculations with Cryptosporidium parvum as a means of immunization for production of monoclonal antibodies.
Tilley M; Eggleston MT; Upton SJ
FEMS Microbiol Lett; 1993 Oct; 113(2):235-40. PubMed ID: 8262371
[TBL] [Abstract][Full Text] [Related]
24. Protection from Cryptosporidium parvum infection by gammadelta T cells in mice that lack alphabeta T cells.
Eichelberger MC; Suresh P; Rehg JE
Comp Med; 2000 Jun; 50(3):270-6. PubMed ID: 10894490
[TBL] [Abstract][Full Text] [Related]
25. Identification of a 15-kilodalton surface glycoprotein on sporozoites of Cryptosporidium parvum.
Tilley M; Upton SJ; Fayer R; Barta JR; Chrisp CE; Freed PS; Blagburn BL; Anderson BC; Barnard SM
Infect Immun; 1991 Mar; 59(3):1002-7. PubMed ID: 1705238
[TBL] [Abstract][Full Text] [Related]
26. Enzyme immunoassay of Cryptosporidium-specific immunoglobulin G antibodies to assess longitudinal infection trends in six communities in British Columbia, Canada.
Ong CS; Li AS; Priest JW; Copes R; Khan M; Fyfe MW; Marion SA; Roberts JM; Lammie PJ; Isaac-Renton JL
Am J Trop Med Hyg; 2005 Aug; 73(2):288-95. PubMed ID: 16103592
[TBL] [Abstract][Full Text] [Related]
27. Targeted disruption of CSL ligand-host cell receptor interaction in treatment of Cryptosporidium parvum infection.
Riggs MW; Schaefer DA; Kapil SJ; Barley-Maloney L; Perryman LE; McNeil MR
J Eukaryot Microbiol; 2001; Suppl():44S-46S. PubMed ID: 11906075
[No Abstract] [Full Text] [Related]
28. Cryptosporidium parvum sporozoite pellicle antigen recognized by a neutralizing monoclonal antibody is a beta-mannosylated glycolipid.
Riggs MW; McNeil MR; Perryman LE; Stone AL; Scherman MS; O'Connor RM
Infect Immun; 1999 Mar; 67(3):1317-22. PubMed ID: 10024577
[TBL] [Abstract][Full Text] [Related]
29. Determination of the specificities of monoclonal and polyclonal antibodies to Neospora, Toxoplasma and Cryptosporidium by fluorescent antibody test (FAT).
Latif BM; Jakubek EB
Trop Biomed; 2008 Dec; 25(3):225-31. PubMed ID: 19287361
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Cryptosporidium parvum infection of a mammalian cell culture by recombinant scFv antibodies.
Pokorny NJ; Boulter-Bitzer JI; Hall JC; Trevors JT; Lee H
Antonie Van Leeuwenhoek; 2008 Oct; 94(3):353-64. PubMed ID: 18581250
[TBL] [Abstract][Full Text] [Related]
31. A new antigen of Cryptosporidium parvum micronemes possessing epitopes cross-reactive with macrogamete granules.
Bonnin A; Dubremetz JF; Camerlynck P
Parasitol Res; 1993; 79(1):8-14. PubMed ID: 7682329
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a major sporozoite surface glycoprotein of Cryptosporidum parvum.
Winter G; Gooley AA; Williams KL; Slade MB
Funct Integr Genomics; 2000 Nov; 1(3):207-17. PubMed ID: 11793239
[TBL] [Abstract][Full Text] [Related]
33. Characterization of an immunogenic glycocalyx on the surfaces of Cryptosporidium parvum oocysts and sporozoites.
Nanduri J; Williams S; Aji T; Flanigan TP
Infect Immun; 1999 Apr; 67(4):2022-4. PubMed ID: 10085053
[TBL] [Abstract][Full Text] [Related]
34. Cross-reactivity of polyclonal serum antibodies generated against Cryptosporidium parvum oocysts.
Ortega-Mora LM; Troncoso JM; Rojo-Vázquez FA; Gómez-Bautista M
Infect Immun; 1992 Aug; 60(8):3442-5. PubMed ID: 1639512
[TBL] [Abstract][Full Text] [Related]
35. Kinetics of Cryptosporidium parvum sporozoite neutralization by monoclonal antibodies, immune bovine serum, and immune bovine colostrum.
Perryman LE; Riggs MW; Mason PH; Fayer R
Infect Immun; 1990 Jan; 58(1):257-9. PubMed ID: 2294054
[TBL] [Abstract][Full Text] [Related]
36. Production and characterization of a monoclonal antibody against nucleoside triphosphate hydrolase from Toxoplasma gondii.
Kikuchi T; Nagata T; Furuta T
J Eukaryot Microbiol; 2001; Suppl():195S-196S. PubMed ID: 11906060
[No Abstract] [Full Text] [Related]
37. The immunological selection of recombinant peptides from Cryptosporidium parvum reveals 14 proteins expressed at the sporozoite stage, 7 of which are conserved in other apicomplexa.
Trasarti E; Pizzi E; Pozio E; Tosini F
Mol Biochem Parasitol; 2007 Apr; 152(2):159-69. PubMed ID: 17267054
[TBL] [Abstract][Full Text] [Related]
38. Effects of a novel anti-exospore monoclonal antibody on microsporidial Nosema bombycis germination and reproduction in vitro.
Zhang F; Lu X; Kumar VS; Zhu H; Chen H; Chen Z; Hong J
Parasitology; 2007 Oct; 134(Pt 11):1551-8. PubMed ID: 17577423
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity-based design of a synthetic malaria peptide eliciting sporozoite inhibitory antibodies in a virosomal formulation.
Okitsu SL; Kienzl U; Moehle K; Silvie O; Peduzzi E; Mueller MS; Sauerwein RW; Matile H; Zurbriggen R; Mazier D; Robinson JA; Pluschke G
Chem Biol; 2007 May; 14(5):577-87. PubMed ID: 17524988
[TBL] [Abstract][Full Text] [Related]
40. Production of immunological probes raised against Enterocytozoon bieneusi and Encephalitozoon intestinalis, two microsporidian species causing intestinal infections in man.
Achbarou A; Thellier M; Accoceberry I; Prigneau O; Bouladoux N; Datry A; Mazier D; Desportes-Livage I
J Eukaryot Microbiol; 1999; 46(5):32S-33S. PubMed ID: 10519236
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
